How the Gene Therapy Market Will Grow: Key Trends, Market Size, and Opportunities Beyond 2025
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Major Innovations Are Driving the Accelerated Growth of the Gene Therapy Market?
The escalating rate of cancer and other targeted diseases is demanding effective remedies, thus fueling the expansion of the gene therapy market. The increasing global cancer incidence will likely foster the growth of the gene therapy market in the years to come. For instance, the American Cancer Society estimated in January 2022 that approximately 1.9 million fresh cancer diagnoses and 609,360 cancer-related deaths would occur in the US in a single year, roughly translating to 1,670 deaths each day. The most prevalent cancer types worldwide include lung, prostate, bowel, and female breast cancer, representing 43 percent of all new cancer diagnoses. Hence, the global surge in cancer rates is likely to stimulate the demand for the gene therapy market in the future. In oncology, gene therapy offers one of the most efficient treatment approaches. The process involves implanting new genes into a cancer cell or its surrounding tissue to induce cell death or inhibit cancer growth.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3395&type=smp
#What Growth Opportunities Will Drive the Gene Therapy Market’s CAGR Through 2034?
In the past few years, the market size of gene therapy has seen a significant surge. The market, which is currently valued at $12.52 billion in 2024, is projected to escalate to $16.36 billion in 2025, with a compound annual growth rate (CAGR) of 30.7%. Factors such as an increase in pharmaceutical R&D spending, augmented public-private collaborations, governmental funding, and a spike in instances of spinal muscular atrophy have heavily contributed to this historical growth phase.
The gene therapy market is poised for rapid expansion in the upcoming years. The anticipated growth will have it reach a worth of $31.48 billion by 2029, with a compound annual growth rate (CAGR) of 17.8%. This predicted growth during the forecast period is largely a result of factors such as a spike in cancer incidents, an aging global population, increased expenditure in research and development in the pharmaceutical segment, and heightened attention on gene therapy. Key trends forecasted for this period include obtaining regulatory approvals to enhance business operations, fortifying business activity via strategic collaborations and partnerships, broadening business capacity through strategic acquisitions, and intensifying operational capabilities through business expansion.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3395
What Are the Most Significant Market Trends Transforming theGene Therapy Market?
Machine learning and artificial intelligence are slowly but surely making their mark in the gene therapy market. AI mimics human cognition in machines, which are programmed to demonstrate inherent intelligence, with machine learning forming a component of this. It assists companies in the gene therapy market in conducting in-depth data analysis, providing insights on tumor and immune cell interactions, and delivering a more precise appraisal of tissue samples, often a point of contention among various evaluators. Take, for instance, in May 2023, Form Bio, a US-based biotechnology software firm, unveiled its revolutionary AI-powered solution, FORMsightAI, designed to predict and enhance the production outputs of cell and gene therapy constructs. This comprehensive solution integrates revolutionary, flexible AI models with Form Bio’s integral platform and a proficient team of computational life science experts possessing backgrounds in biology, bioinformatics, and data science. FORMsightAI takes on frequent problems encountered by cell and gene therapy developers, such as construct truncations and manufacturing contaminations, which are primarily responsible for unacceptably low production yields, drawn-out market-ready timelines, and issues concerning therapeutic safety.
What Are the Top Market Players Propelling the Growth of theGene Therapy Industry?
Major companies operating in the gene therapy market include UniQure NV, REGENXBIO Inc., Bristol-Myers Squibb, BioMarin Pharmaceuticals Inc., Jazz Pharmaceuticals Inc., Biocon, Cipla, EdiGene Inc, Takeda Pharmaceutical, Daiichi Sankyo Company, Mitsubishi Tanabe Pharma, Merck, GE Healthcare, Lonza, Pfizer, Cellular Biomedicine Group, GenScript, Albumedix Ltd, Catalent, Freeline Therapeutics, DiNAQOR AG, Vivet Therapeutics, Allergan, Amgen, Biocad, Celgene Corporation, Johnson & Johnson, Eli Lilly and Company, AstraZeneca, Bayer AG, Juno Therapeutics, Allogene Therapeutics, Bluebird Bio, Regen BioPharma, Bellicum, Biotchpharma, BrainStorm Cell Therapeutics, Pluristem, Sanofi
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report
Which Primary Segments of the Gene Therapy Market Are Driving Growth and Industry Transformations?
The gene therapy market covered in this report is segmented –
1) By Gene Therapy Type: Germline Therapy, Somatic Cell Therapy
2) By Vector: Viral Vector, Non-Viral Vector
3) By Application: Oncology, Orphan Disease, Knee Osteoarthritis, Neurological Disorders
4) By End Users: Biopharmaceutical Companies, Research Institutes, Other End Users
Subsegments:
1) By Germline Therapy: Inherited Disease Treatment, Genetic Modification Of Embryos, Gene Editing Techniques, Ethical And Regulatory Considerations
2) By Somatic Cell Therapy: Cancer Gene Therapy, Monogenic Disorder Treatment, Gene Replacement Therapy, RNA-Based Therapies, Gene Editing Techniques
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=3395&type=smp
Which Regions Are Key Players in the Growth of the #What Major Innovations Are Driving the Accelerated Growth of the Gene Therapy Market?# Market?
North America was the largest region in the gene therapy market in 2024. The regions covered in the gene therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Reports Similar to the Global Gene Therapy Market 2025, By The Business Research Company:
Colorectal Cancer Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/colorectal-cancer-drugs-global-market-report
Thyroid Cancer Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/thyroid-cancer-drugs-global-market-report
Hematology Analyzers and Reagents Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
